Travoprost Solution
Product Images NDC 51407-731

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Travoprost (NDC 51407-731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-731-25cb.jpg (51407 731 25cb)

This is a description of a medication called Travoprost Ophthalmic Solution. It is an ionic buffered solution that is used only in the eyes. The usual dosage is one drop in the affected eye(s) once daily in the evening. The medication is preserved in the bottle with an ionic buffered system and contains active ingredient of travoprost 0.04 mg. The medication is manufactured by Apotex Inc. and marketed by GSMS, incorporated. The package is not child-resistant, so keep it out of reach of children.*

FDA Label Image

51407-731-25ol.jpg (51407 731 25ol)

This is a description of an ophthalmic solution with a National Drug Code of 51407-731-25. It is a solution that contains Travoprost at a concentration of 0.04mg per mL. The solution is ionically buffered and is meant for use in the eyes only. The dosage information should be obtained from the accompanying prescribing information. The solution should be kept out of reach of children and stored between 2° - 25°C (36° - 77°F). The solution is manufactured by Apotex Inc. and marketed by GSMS, Incorporated in Camarillo, CA. The description is helpful for understanding the contents, dosage, and storage instructions of this ophthalmic solution.*

FDA Label Image

Chemical (Chemical)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.